1. Home
  2. BLLN vs RNST Comparison

BLLN vs RNST Comparison

Compare BLLN & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLLN

BillionToOne Inc.

N/A

Current Price

$76.16

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

RNST

Renasant Corporation

HOLD

Current Price

$40.01

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
RNST
Founded
2016
1904
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.7B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
BLLN
RNST
Price
$76.16
$40.01
Analyst Decision
Buy
Strong Buy
Analyst Count
7
3
Target Price
$126.71
$43.00
AVG Volume (30 Days)
372.4K
573.2K
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
2.31%
EPS Growth
N/A
N/A
EPS
N/A
2.07
Revenue
N/A
N/A
Revenue This Year
$46.29
$31.72
Revenue Next Year
$30.14
$4.67
P/E Ratio
N/A
$19.32
Revenue Growth
N/A
N/A
52 Week Low
$61.96
$32.63
52 Week High
$138.70
$42.11

Technical Indicators

Market Signals
Indicator
BLLN
RNST
Relative Strength Index (RSI) 45.20 60.30
Support Level $64.99 $36.72
Resistance Level $83.20 $39.99
Average True Range (ATR) 6.09 0.92
MACD -1.22 -0.04
Stochastic Oscillator 23.02 48.94

Price Performance

Historical Comparison
BLLN
RNST

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has two reportable segments: Community banks and Wealth management. With its Community Banks segment, the company provides a range of financial services to individuals and small businesses. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

Share on Social Networks: